Avalo to Present at Oppenheimer’s 33rd Annual Healthcare Conference
WAYNE, Pa. and ROCKVILLE, Md., March 07, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:AVTX) announced today that Garry A. Neil, M.D., President and Chief Executive Officer, will present virtually at Oppenheimer’s 33rd Annual Healthcare Conference on Monday, March 13, 2023 at 1:20 p.m. ET.
Related news for (AVTX)
- Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
- Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
- Notable 28 March 2024 Headlines
- Avalo Acquires AlmataBio and Agrees to Private Placement Financing of up to $185 Million
- Avalo Therapeutics Announces 1-for-240 Reverse Stock Split